Next Article in Journal
How Do Young Women with Cancer Experience Oncofertility Counselling during Cancer Treatment? A Qualitative, Single Centre Study at a Danish Tertiary Hospital
Previous Article in Journal
The Plasma Membrane Ca2+ Pump PMCA4b Regulates Melanoma Cell Migration through Remodeling of the Actin Cytoskeleton
Article

A Drastic Shift in Lipid Adducts in Colon Cancer Detected by MALDI-IMS Exposes Alterations in Specific K+ Channels

1
Department of Physical Chemistry, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain
2
Institut d’Investigació Sanitària Illes Balears (IdISBa, Health Research Institute of the Balearic Islands), 07120 Palma, Spain
3
Research Unit, Hospital Universitari Son Espases, 07120 Palma, Spain
4
Research Department, IMG Pharma Biotech S.L., BIC Bizkaia (612), 48160 Derio, Spain
5
Pathology Anatomy Unit, Hospital Universitari Son Espases, 07120 Palma, Spain
6
Gastroenterology Unit, Hospital Universitari Son Espases, 07120 Palma, Spain
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Current address: Université Catholique de Louvin, Brussels, Belgium
Academic Editor: Isabelle Van Seuningen
Cancers 2021, 13(6), 1350; https://doi.org/10.3390/cancers13061350
Received: 3 February 2021 / Revised: 4 March 2021 / Accepted: 10 March 2021 / Published: 17 March 2021
Colorectal cancer (CRC) is one of the most preventable yet deadliest cancers, one reason being that it involves very different lesions. Currently, there is a great international effort to improve CRC classification using as many molecular features as possible. A cutting-edge technique, imaging mass spectrometry, is used to enable the visualization of the bidimensional (2D) distribution of molecules across tissues in order to study how the composition of the cell membrane, in particular membrane lipids, changes in tumors. Our previous studies indicate that lipid composition is highly sensitive to cell alterations. Importantly, during the analysis, we are also able to establish changes in charged lipids, observations that can be misinterpreted. A close study of our results alongside information from public databases leads to the identification of gene coding for a potassium channel that could account for our observations and could represent a suitable target for drug development.
Even though colorectal cancer (CRC) is one of the most preventable cancers, it is one of the deadliest, and recent data show that the incidence in people <50 years has unexpectedly increased. While new techniques for CRC molecular classification are emerging, no molecular feature is as yet firmly associated with prognosis. Imaging mass spectrometry (IMS) lipidomic analyses have demonstrated the specificity of the lipid fingerprint in differentiating pathological from healthy tissues. During IMS lipidomic analysis, the formation of ionic adducts is common. Of particular interest is the [Na+]/[K+] adduct ratio, which already functions as a biomarker for homeostatic alterations. Herein, we show a drastic shift of the [Na+]/[K+] adduct ratio in adenomatous colon mucosa compared to healthy mucosa, suggesting a robust increase in K+ levels. Interrogating public databases, a strong association was found between poor diagnosis and voltage-gated potassium channel subunit beta-2 (KCNAB2) overexpression. We found this overexpression in three CRC molecular subtypes defined by the CRC Subtyping Consortium, making KCNAB2 an interesting pharmacological target. Consistently, its pharmacological inhibition resulted in a dramatic halt in commercial CRC cell proliferation. Identification of potential pharmacologic targets using lipid adduct information emphasizes the great potential of IMS lipidomic techniques in the clinical field. View Full-Text
Keywords: colorectal cancer; lipidomics; ion adducts; potassium channels colorectal cancer; lipidomics; ion adducts; potassium channels
Show Figures

Graphical abstract

MDPI and ACS Style

Garate, J.; Maimó-Barceló, A.; Bestard-Escalas, J.; Fernández, R.; Pérez-Romero, K.; Martínez, M.A.; Payeras, M.A.; Lopez, D.H.; Fernández, J.A.; Barceló-Coblijn, G. A Drastic Shift in Lipid Adducts in Colon Cancer Detected by MALDI-IMS Exposes Alterations in Specific K+ Channels. Cancers 2021, 13, 1350. https://doi.org/10.3390/cancers13061350

AMA Style

Garate J, Maimó-Barceló A, Bestard-Escalas J, Fernández R, Pérez-Romero K, Martínez MA, Payeras MA, Lopez DH, Fernández JA, Barceló-Coblijn G. A Drastic Shift in Lipid Adducts in Colon Cancer Detected by MALDI-IMS Exposes Alterations in Specific K+ Channels. Cancers. 2021; 13(6):1350. https://doi.org/10.3390/cancers13061350

Chicago/Turabian Style

Garate, Jone, Albert Maimó-Barceló, Joan Bestard-Escalas, Roberto Fernández, Karim Pérez-Romero, Marco A. Martínez, Mª A. Payeras, Daniel H. Lopez, José A. Fernández, and Gwendolyn Barceló-Coblijn. 2021. "A Drastic Shift in Lipid Adducts in Colon Cancer Detected by MALDI-IMS Exposes Alterations in Specific K+ Channels" Cancers 13, no. 6: 1350. https://doi.org/10.3390/cancers13061350

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop